TIS tissue therapies limited

Mel Bridges

  1. 894 Posts.
    Interesting note on Mel Bridges resignation announcement from BLT. Hopefully, TIS might get some benefit.

    Dr Mel Bridges commented,“With the significant advances made recently, Benitec has matured to a well funded, stable, clinical stage company and I am proud to have played a part in its development. My resignation from the Benitec Board will allow me more time to focus on my Brisbane ‐ based boards and personal business opportunities.”
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.